Noveome: Pittsburgh's Noveome Biotherapeutics closed $20.7M of a Series E
The raise so far - half of an expected $40.2 million - is already one of the city's biggest of the year.
Read full article »
Noveome is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory and neurological disorders.
Read more